The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
121681784 12168178 4 F 20141126 20160830 20160310 20160914 EXP JP-INCYTE CORPORATION-2015IN003597 INCYTE 74.72 YR F Y 42.00000 KG 20160914 CN JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
121681784 12168178 1 PS JAKAFI RUXOLITINIB 1 Oral 5 MG, QD 430 MG Y 202192 5 MG TABLET QD
121681784 12168178 2 SS JAKAFI RUXOLITINIB 1 Oral 5 MG, QD 430 MG Y 202192 5 MG TABLET QD
121681784 12168178 3 SS JAKAFI RUXOLITINIB 1 Oral 5 MG, BID 430 MG Y 202192 5 MG TABLET BID
121681784 12168178 4 SS JAKAFI RUXOLITINIB 1 Oral 5 MG, QD 430 MG Y 202192 5 MG TABLET QD
121681784 12168178 5 SS JAKAFI RUXOLITINIB 1 Oral 5 MG, QD 430 MG Y 202192 5 MG TABLET QD
121681784 12168178 6 SS FUROSEMIDE. FUROSEMIDE 1 Unknown UNK 0
121681784 12168178 7 SS FUROSEMIDE. FUROSEMIDE 1 Unknown UNK 0
121681784 12168178 8 C PREDONINE PREDNISOLONEPREDNISOLONE ACETATEPREDNISOLONE SODIUM SUCCINATE 1 Oral 5 MG, UNK 0 5 MG
121681784 12168178 9 C PREDONINE PREDNISOLONEPREDNISOLONE ACETATEPREDNISOLONE SODIUM SUCCINATE 1 Oral 5 MG, UNK 0 5 MG
121681784 12168178 10 C THROMBIN THROMBIN 1 Unknown UNK 0
121681784 12168178 11 C THROMBIN THROMBIN 1 Unknown UNK 0
121681784 12168178 12 C ALBUMIN ALBUMIN HUMAN 1 Unknown UNK 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
121681784 12168178 1 Myelofibrosis
121681784 12168178 6 Hypernatraemia
121681784 12168178 8 Myelofibrosis
121681784 12168178 10 Product used for unknown indication
121681784 12168178 12 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
121681784 12168178 OT
121681784 12168178 DE

Reactions reported

Event ID CASEID DRUG REC ACT PT
121681784 12168178 Anaemia
121681784 12168178 Bacterial infection
121681784 12168178 Blood pressure diastolic decreased
121681784 12168178 Dehydration
121681784 12168178 Fatigue
121681784 12168178 Gastric varices haemorrhage
121681784 12168178 Gingivitis
121681784 12168178 Hyperkalaemia
121681784 12168178 Hypernatraemia
121681784 12168178 Malaise
121681784 12168178 Myelofibrosis
121681784 12168178 Oedema peripheral
121681784 12168178 Oral herpes
121681784 12168178 Platelet count decreased
121681784 12168178 Renal failure
121681784 12168178 Somnolence

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
121681784 12168178 1 20141120 20141217 0
121681784 12168178 2 20150107 20150811 0
121681784 12168178 3 20150812 20150909 0
121681784 12168178 4 20150910 0
121681784 12168178 5 20151212 20160115 0
121681784 12168178 8 20141009 20141119 0
121681784 12168178 9 20141218 0